Accessibility Menu
 

Satellos Bioscience

(NASDAQ) MSLE

Current Price$7.61
Market Cap$149.15M
Since IPO (2021)-67%
5 Year-62%
1 Year+29%
1 Month+16%

Satellos Bioscience Financials at a Glance

Market Cap

$149.15M

Revenue (TTM)

$0.00

Net Income (TTM)

$20.87M

EPS (TTM)

$-1.73

P/E Ratio

-4.15

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$7.61

Volume

2,291

Open

$7.28

Previous Close

$7.16

Daily Range

$7.28 - $7.90

52-Week Range

$4.53 - $13.39

MSLE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Satellos Bioscience

Industry

Biotechnology

Employees

18

CEO

Frank Gleeson, MBA

Headquarters

Toronto, ON M5J 2J1, CA

MSLE Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-66%

Return on Capital

-21%

Return on Assets

-26%

Earnings Yield

-24.10%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$149.15M

Shares Outstanding

20.83M

Volume

2.29K

Avg. Volume

80.98K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$19.38M

EBITDA

$19.56M

Operating Cash Flow

$17.40M

Capital Expenditure

$4.18K

Free Cash Flow

$17.41M

Cash & ST Invst.

$48.67M

Total Debt

$0.00

Satellos Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$149.15M

N/A

Market Cap/Employee

$10.65M

N/A

Employees

14

N/A

Net Income

$5.82M

+12.1%

EBITDA

$5.96M

-61.2%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$34.61M

+99.7%

Accounts Receivable

$205.00K

+45.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-25.56%

N/A

Return on Invested Capital

-20.67%

N/A

Free Cash Flow

$4.13M

-27.5%

Operating Cash Flow

$4.13M

-27.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7136.82-0.01%
^DJIDJI
$49145.23-0.00%
^IXICNASDAQ
$24655.74-0.01%
BTCBitcoin
$76184.00-0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$83.67-0.02%
NOKNokia
$11.11+0.04%
POETPoet Technologies
$7.86-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.20-0.01%

Questions About MSLE

What is the current price of Satellos Bioscience?

Satellos Bioscience is trading at $7.61 per share.

What is the 52-week range for Satellos Bioscience?

Over the past 52 weeks, Satellos Bioscience has traded between $4.53 and $13.39.

How much debt does Satellos Bioscience have?

As of the most recent reporting period, Satellos Bioscience reported total debt of N/A.

How much cash does Satellos Bioscience have on hand?

Satellos Bioscience reported $9.80M in cash and cash equivalents in its most recent financial results.

What is Satellos Bioscience’s dividend yield?

Satellos Bioscience does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.